Guggenheim Capital’s Insulet PODD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.63M | Buy |
36,950
+6,283
| +20% | +$1.05M | 0.04% | 418 |
|
|
2026
Q1 | $6.44M | Sell |
30,667
-2,847
| -8% | -$715K | 0.05% | 374 |
|
|
2025
Q4 | $9.53M | Buy |
33,514
+1,750
| +6% | +$547K | 0.07% | 287 |
|
|
2025
Q3 | $9.81M | Buy |
31,764
+4,318
| +16% | +$1.35M | 0.07% | 273 |
|
|
2025
Q2 | $8.62M | Buy |
27,446
+944
| +4% | +$272K | 0.07% | 287 |
|
|
2025
Q1 | $6.96M | Buy |
26,502
+4,147
| +19% | +$1.12M | 0.06% | 331 |
|
|
2024
Q4 | $5.84M | Buy |
22,355
+4,555
| +26% | +$1.15M | 0.05% | 383 |
|
|
2024
Q3 | $4.14M | Buy |
17,800
+7,642
| +75% | +$1.57M | 0.03% | 590 |
|
|
2024
Q2 | $2.05M | Sell |
10,158
-4,967
| -33% | -$895K | 0.01% | 808 |
|
|
2024
Q1 | $2.59M | Buy |
15,125
+8,193
| +118% | +$1.53M | 0.02% | 791 |
|
|
2023
Q4 | $1.5M | Buy |
6,932
+1,122
| +19% | +$192K | 0.01% | 971 |
|
|
2023
Q3 | $927K | Buy |
5,810
+235
| +4% | +$52.6K | 0.01% | 1141 |
|
|
2023
Q2 | $1.61M | Sell |
5,575
-1,353
| -20% | -$411K | 0.01% | 950 |
|
|
2023
Q1 | $2.21M | Buy |
6,928
+3,996
| +136% | +$1.18M | 0.02% | 808 |
|
|
2022
Q4 | $863K | Sell |
2,932
-2,697
| -48% | -$744K | 0.01% | 1235 |
|
|
2022
Q3 | $1.29M | Sell |
5,629
-189
| -3% | -$47.3K | 0.01% | 1021 |
|
|
2022
Q2 | $1.27M | Sell |
5,818
-128
| -2% | -$29.1K | 0.01% | 1118 |
|
|
2022
Q1 | $1.58M | Buy |
5,946
+76
| +1% | +$18.7K | 0.01% | 1135 |
|
|
2021
Q4 | $1.56M | Buy |
5,870
+224
| +4% | +$65K | 0.01% | 1177 |
|
|
2021
Q3 | $1.6M | Buy |
5,646
+687
| +14% | +$196K | 0.01% | 1163 |
|
|
2021
Q2 | $1.36M | Buy |
4,959
+337
| +7% | +$91.6K | 0.01% | 1312 |
|
|
2021
Q1 | $1.21M | Buy |
4,622
+1,276
| +38% | +$342K | 0.01% | 1297 |
|
|
2020
Q4 | $855K | Buy |
3,346
+1,596
| +91% | +$396K | 0.01% | 1417 |
|
|
2020
Q3 | $414K | Sell |
1,750
-1,326
| -43% | -$279K | ﹤0.01% | 1509 |
|
|
2020
Q2 | $598K | Buy |
3,076
+1,710
| +125% | +$327K | ﹤0.01% | 1393 |
|
|
2020
Q1 | $226K | Sell |
1,366
-885
| -39% | -$162K | ﹤0.01% | 1635 |
|
|
2019
Q4 | $385K | Buy |
2,251
+366
| +19% | +$61K | ﹤0.01% | 1709 |
|
|
2019
Q3 | $311K | Sell |
1,885
-1,032
| -35% | -$145K | ﹤0.01% | 1830 |
|
|
2019
Q2 | $348K | Sell |
2,917
-1,880
| -39% | -$193K | ﹤0.01% | 1816 |
|
|
2019
Q1 | $456K | Sell |
4,797
-700
| -13% | -$60K | ﹤0.01% | 1724 |
|
|
2018
Q4 | $436K | Sell |
5,497
-480
| -8% | -$40.6K | ﹤0.01% | 1738 |
|
|
2018
Q3 | $633K | Buy |
5,977
+1,780
| +42% | +$167K | ﹤0.01% | 1854 |
|
|
2018
Q2 | $360K | Sell |
4,197
-2,214
| -35% | -$199K | ﹤0.01% | 2121 |
|
|
2018
Q1 | $556K | Sell |
6,411
-107
| -2% | -$8.31K | ﹤0.01% | 2338 |
|
|
2017
Q4 | $450K | Sell |
6,518
-2,678
| -29% | -$176K | ﹤0.01% | 2393 |
|
|
2017
Q3 | $506K | Buy |
9,196
+1,164
| +14% | +$63.6K | ﹤0.01% | 2383 |
|
|
2017
Q2 | $413K | Buy |
8,032
+1,563
| +24% | +$67.9K | ﹤0.01% | 2459 |
|
|
2017
Q1 | $278K | Sell |
6,469
-587
| -8% | -$25.2K | ﹤0.01% | 2567 |
|
|
2016
Q4 | $266K | Buy |
+7,056
| New | +$263K | ﹤0.01% | 2625 |
|
Other funds holding PODD
Guggenheim Capital's PODD Position: Q2 2026 in Review
Guggenheim Capital increased its Insulet (PODD) stake by 20% in Q2 2026, buying an estimated $1.05M and bringing the position to 36,950 shares worth $5.63M. The position accounts for 0.04% of the portfolio, ranked #418.
Guggenheim Capital first reported a position in PODD in Q4 2016 and has held it in 39 quarters since. The position peaked at $9.81M in Q3 2025. 723 funds tracked by Wall St. Rank hold PODD as of Q2 2026.
- Guggenheim Capital held 36,950 shares of Insulet worth $5.63M as of Q2 2026.
- Guggenheim Capital bought 6,283 Insulet shares in Q2 2026, an estimated $1.05M.
- Insulet made up 0.04% of Guggenheim Capital's portfolio in Q2 2026, its #418 holding.
- Guggenheim Capital first reported a position in Insulet in Q4 2016 and has held it in 39 quarters since.
- Guggenheim Capital's Insulet position peaked at $9.81M in Q3 2025.
- 723 funds tracked by Wall St. Rank held Insulet as of Q2 2026.
Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.